Healthcare -
Biotechnology - NASDAQ - US
$ 85.3
-2.88 %
$ 10.6 B
Market Cap
-18.87
P/E
PCVX - COST OF REVENUE
Cost of Revenue PCVX - Vaxcyte, Inc.
75 M
LAST VALUE
545.50%
2 YEAR CAGR
135.43%
5 YEAR CAGR
0.00%
10 YEAR CAGR